CVE-2020-14486 Explained : Impact and Mitigation

OpenClinic GA 5.09.02 and 5.89.05b are affected by a vulnerability that allows attackers to bypass permission checks, potentially leading to unauthorized command execution.

Understanding CVE-2020-14486

OpenClinic GA versions 5.09.02 and 5.89.05b are susceptible to improper authorization, posing a risk of unauthorized command execution.

What is CVE-2020-14486?

An attacker exploiting this vulnerability can circumvent permission checks in OpenClinic GA, enabling the execution of unauthorized commands by disregarding permission failure redirects.

The Impact of CVE-2020-14486

The vulnerability's CVSS v3.1 base score of 6.3 categorizes it as medium severity, with low impacts on confidentiality, integrity, and availability. The attack complexity is low, requiring no user interaction.

Technical Details of CVE-2020-14486

OpenClinic GA's vulnerability details and affected systems.

Vulnerability Description

Attackers can bypass permission checks in OpenClinic GA 5.09.02 and 5.89.05b, potentially leading to unauthorized command execution.

Affected Systems and Versions

Product: OpenClinic GA
Vendor: open source
Vulnerable Versions: 5.09.02, 5.89.05b

Exploitation Mechanism

Attack Vector: Network
Privileges Required: Low
User Interaction: None
Scope: Unchanged
Vector String: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

Mitigation and Prevention

Steps to mitigate and prevent the CVE-2020-14486 vulnerability.

Immediate Steps to Take

Upgrade OpenClinic GA to the latest version to apply necessary fixes.

Long-Term Security Practices

Regularly update software to address security vulnerabilities.
Implement proper authorization mechanisms to prevent unauthorized access.

Patching and Updates

OpenClinic GA is aware of the vulnerabilities but has not confirmed their resolution. Ensure you are using the latest version to mitigate risks.